AstraZeneca PLC is 190.3x more valuable than Tyra Biosciences, Inc. by market capitalization ($286.27 B vs $1.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TYRA | AZN |
|---|---|---|
| Market cap | $1.50 B | $286.27 B |
| US-listed rank | #2316 | #45 |
| Net income (latest FY) | -$119.95M | - |
| SEC filings | 396 | 1,004 |
AstraZeneca PLC is 190.3x more valuable than Tyra Biosciences, Inc. by market capitalization ($286.27 B vs $1.50 B).
Full pages: Tyra Biosciences, Inc. and AstraZeneca PLC, or browse the full rankings.